prikaz prve stranice dokumenta A modern approach to the treatment of plaque psoriasis
  Preuzmi
PDF 1.13 MB
Znanstveni rad - Pregledni rad
A modern approach to the treatment of plaque psoriasis
Acta Pharmaceutica, 69 (2019), 4; 511-523. https://doi.org/10.2478/acph-2020-0047
Ledić Drvar, Daniela; Vlahinić, Tomislav; Maleš, Željan; Turčić, Petra; Čeović, Romana

Citirajte ovaj rad

Ledić Drvar, D., Vlahinić, T., Maleš, Ž., Turčić, P. i Čeović, R. (2019). A modern approach to the treatment of plaque psoriasis. Acta Pharmaceutica, 69. (4), 511-523. doi: 10.2478/acph-2020-0047

Ledić Drvar, Daniela, et al. "A modern approach to the treatment of plaque psoriasis." Acta Pharmaceutica, vol. 69, br. 4, 2019, str. 511-523. https://doi.org/10.2478/acph-2020-0047

Ledić Drvar, Daniela, Tomislav Vlahinić, Željan Maleš, Petra Turčić i Romana Čeović. "A modern approach to the treatment of plaque psoriasis." Acta Pharmaceutica 69, br. 4 (2019): 511-523. https://doi.org/10.2478/acph-2020-0047

Ledić Drvar, D., et al. (2019) 'A modern approach to the treatment of plaque psoriasis', Acta Pharmaceutica, 69(4), str. 511-523. doi: 10.2478/acph-2020-0047

Ledić Drvar D, Vlahinić T, Maleš Ž, Turčić P, Čeović R. A modern approach to the treatment of plaque psoriasis. Acta Pharmaceutica [Internet]. 2019. [pristupljeno 04.12.2024.];69(4):511-523. doi: 10.2478/acph-2020-0047

D. Ledić Drvar, T. Vlahinić, Ž. Maleš, P. Turčić i R. Čeović, "A modern approach to the treatment of plaque psoriasis", Acta Pharmaceutica, vol. 69, br. 4, str. 511-523, 2019. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:163:659251. [Citirano: 04.12.2024.]

Za citiranje koristite ovu mrežnu adresu: https://urn.nsk.hr/urn:nbn:hr:163:659251
Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.
Podaci o radu
Naslov (engleski)A modern approach to the treatment of plaque psoriasis
AutorDaniela Ledić Drvar
AutorTomislav Vlahinić
AutorŽeljan Maleš
AutorPetra Turčić
AutorRomana Čeović
Autorova ustanovaSveučilište u Zagrebu
Farmaceutsko-biokemijski fakultet
(Zavod za farmaceutsku botaniku)
Autorova ustanovaSveučilište u Zagrebu
Farmaceutsko-biokemijski fakultet
(Zavod za farmakologiju)
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Farmacija
Farmacija
Sažetak (engleski)
Psoriasis is a common chronic inflammatory skin disease which affects 0.5–1 % of children and 2–3 % of the adult population. In Croatia, 1.6 % of the population suffer from psoriasis. Distribution of the disease is bi-modal, with the first peak at the age of 20–30, and the second at the age of 50–60. The etiopathogenesis of the disease is multifactorial, the key factors being genetic predisposition combined with immunological disorders, environmental factors and skin barrier damage. There are several clinical variants of the disease. The main signalling pathways in psoriasis include TNF-α, IL-23 and IL-17. Topical agents are used for the treatment of the mild form, and the systemic conventional therapy is used for the treatment of moderate to severe forms of the disease. In cases where’s no response, or intolerance or contraindications are present, new targeted medications are to be administered. Development in the field of immunogenetics of psoriasis leads to personalized medicine.
Ključne riječi (engleski)
Jezikengleski
Vrsta publikacijeZnanstveni rad - Pregledni rad
Status objaveObjavljen
Vrsta recenzijeRecenziran - međunarodna recenzija
Verzija publikacijeObjavljena verzija rada (izdavačev PDF)
Naslov časopisaActa Pharmaceutica
Brojčani podacivol. 69, br. 4, str. 511-523
p-ISSN1330-0075
e-ISSN1846-9558
DOIhttps://doi.org/10.2478/acph-2020-0047
URN:NBNurn:nbn:hr:163:659251
Datum objave publikacije2019
URL dokumentahttps://hrcak.srce.hr/221406
Vrsta resursaTekst
Prava pristupaOtvoreni pristup
Uvjeti korištenjaIkona licence Zaštićeno autorskim pravom.
Datum i vrijeme pohrane2020-04-06 17:05:52